Surgery plus radiation for bile duct cancer with lymph node spread
Part of Cancer, Digestive system clinical trials.
This trial is testing whether removing the main tumor and some lymph nodes, followed by radiation, helps people with bile duct cancer that has spread to nearby lymph nodes. It aims to control the cancer and possibly improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Your cancer is in the bile ducts (tubes that carry bile from the liver to the intestine) and has spread to nearby lymph nodes.
- Your cancer has not spread to distant organs like the liver or lungs, except for a few specific nearby nodes that may be treated later.
- You have not had radiation to the belly area or a liver transplant before.
- You have not had local treatments like injecting medicine directly into the tumor or using heat/cold to destroy it for this cancer.
- Your liver, kidney, and blood tests are within acceptable ranges, and you are generally able to care for yourself (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug combination given before surgery to shrink bile duct cancer tumors, potentially making surgery more successful. It is for patients whose cancer is locally advanced or has spread to only a few places.
This trial tests a combination of drugs given before surgery to shrink bile duct cancer and possibly improve outcomes. The drugs include an immunotherapy (tislelizumab) and three chemotherapy agents (gemcitabine, cisplatin, and S-1).
This study tests whether combining chemotherapy and radiation therapy after surgery improves outcomes for patients with bile duct or gallbladder cancer. It's designed for patients whose surgery showed signs the cancer might come back.
This trial uses a test called MiniPDX, which grows a tiny sample of your tumor in mice to see which drugs work best. After your surgery, you'll receive chemotherapy chosen specifically for your cancer to help prevent it from coming back.
This trial compares two different surgical approaches for treating bile duct cancer (cholangiocarcinoma) to see which method works better and is safer. You would undergo surgery and have your recovery and outcomes closely monitored.
This trial tests a chemotherapy approach after surgery for bile duct or gallbladder cancers. The goal is to see if giving chemotherapy based on a detailed analysis of your tumor (called 3D-PTA) helps prevent the cancer from coming back.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.